22 May 2017 - Deborah Wilkes
Archived
Consumer advertising for the emergency contraceptive ulipristal – the active ingredient of HRA Pharma's EllaOne – will be allowed in Australia from 1 February 2018, if a decision by the country's Advisory Committee on Medicines Scheduling (ACMS) is implemented.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.